Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study To Evaluate The Treatment Pattern Of Moderate-to-Severe Asthma Patients In China
Sponsor: AstraZeneca
Summary
This is a Prospective, Observational, Multicentre Study to describe treatment pattern changes of uncontrolled moderate-to-severe asthma patients in China. Sponsor by Astrazeneca Investment(China) Co., LTD.
Official title: A Prospective, Observational, Multicentre Study To Evaluate The Treatment Pattern Of Moderate-to-Severe Asthma Patients In China
Key Details
Gender
All
Age Range
12 Years - 130 Years
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2024-03-22
Completion Date
2025-03-13
Last Updated
2026-09-04
Healthy Volunteers
No
Conditions
Locations (31)
Research Site
Baoding, China
Research Site
Beijing, China
Research Site
Changsha, China
Research Site
Chengdu, China
Research Site
Chongqing, China
Research Site
Dingzhou, China
Research Site
Hangzhou, China
Research Site
Harbin, China
Research Site
Hefei, China
Research Site
Hohhot, China
Research Site
Jinan, China
Research Site
Kunming, China
Research Site
Liuzhou, China
Research Site
Lu'an, China
Research Site
Luzhou, China
Research Site
Nanchang, China
Research Site
Nanchong, China
Research Site
Qingdao, China
Research Site
Quanzhou, China
Research Site
Shanghai, China
Research Site
Shenzhen, China
Research Site
Tianjin, China
Research Site
Tiaobingshan, China
Research Site
Wenzhou, China
Research Site
Wuhan, China
Research Site
Xi'an, China
Research Site
Xiamen, China
Research Site
Yongzhou, China
Research Site
Zhangjiagang, China
Research Site
Zhengzhou, China
Research Site
Zigong, China